Quantcast

Latest Pharmacology Stories

2014-09-24 16:26:15

PHILADELPHIA, September 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached a final agreement with the U.S. Attorney's Offices for the Eastern District of Pennsylvania and Northern District of Illinois, all 50 states and the District of Columbia to resolve a previously disclosed civil investigation of its sales and marketing practices for a period ending in 2010 relating to ADDERALL XR(R), VYVANSE(R) DAYTRANA(R), LIALDA(R) and...

2014-09-24 12:29:13

New data illustrates importance of drug take-backs to help prevent unnecessary hospitalizations and deaths HARRISBURG, Pa., Sept. 24, 2014 /PRNewswire/ -- To support a nationwide effort to clear homes of potentially dangerous, expired, unused and unwanted prescription drugs, Capital BlueCross is reminding residents to take advantage of the Drug Enforcement Administration's (DEA) National Prescription Drug Take-Back Day from 10 a.m. to 2 p.m. Saturday, Sept. 27. Take-Back Day...

2014-09-24 12:28:59

TORONTO, Sept. 24, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced the appointment of Dr. Floyd R. Sallee as Chief Medical Officer of Ironshore Pharmaceuticals & Development, Inc. ("Ironshore"), Highland's wholly owned principal operating subsidiary. As an expert in pediatric psychopharmacology, Dr. Sallee has been an important adviser and consultant to Ironshore on the development of the Company's investigational drug products, HLD-100 (amphetamine)...

2014-09-24 12:26:06

WASHINGTON, Sept. 24, 2014 /PRNewswire-USNewswire/ -- "When President Ronald Reagan signed the Drug Price Competition and Patent Term Restoration Act 30 years ago today, few could imagine how the law would transform the healthcare landscape. Today, we know that this landmark 'Hatch-Waxman' legislation is responsible for improving the lives of millions of Americans by creating a new framework allowing safe, affordable generic drugs to come to the market. It is instructive to look...

2014-09-24 08:28:14

New addition expands WCG's eClinical offerings for improving clinical trial start-up and management PRINCETON, N.J., Sept. 24, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies. Based near Philadelphia, PA, ePS is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of...

2014-09-24 08:27:40

Press Conference: CANNA-STOCK AT THE HARD ROCK - Sept. 26th @ 10AM TAMPA, Fla., Sept. 24, 2014 /PRNewswire-iReach/ -- THIS FRIDAY, SEPTEMBER 26(TH) 10AM - 5PM Photo - http://photos.prnewswire.com/prnh/20140923/147863 WHAT: CANNA-STOCK AT THE HARD ROCK WHERE: Seminole Hard Rock Hotel & Casino in Hollywood, FL WHO: Marijuana Policy Project, The MedMen, NORML, Steep Hill Labs, Ebbu, and more WHEN: This Friday, September 26(th) 10am - 5pm Press is invited to arrive at 9:00 AM...

2014-09-23 23:14:07

The Strategic Alliance will enable US-based AltMed and Canada’s Vida to collaborate on clinical research, quality assurance, and the cultivation of pharmaceutical-grade cannabis. Ottawa, ON (PRWEB) September 23, 2014 Vida Cannabis Corp. is pleased to announce the signing of a Strategic Alliance Agreement with Florida-based AltMed LLC. The two companies will collaborate on research, quality assurance, and technical expertise. They’ll also pool business development know-how to...

2014-09-23 23:10:36

The Strategic Alliance will enable US-based AltMed and Canada’s Vida to collaborate on clinical research, quality assurance, and the cultivation of pharmaceutical-grade cannabis Sarasota, FL (PRWEB) September 23, 2014 AltMed, a Florida company bringing pharmaceutical industry precision to the development and production of medical cannabis has signed a Strategic Alliance Agreement with Canada’s Vida Cannabis. The two companies will collaborate on research, quality assurance, and...

2014-09-23 23:06:16

Best of the Best in Healthcare Marketing Honored at Gala Event NEW YORK, NY (PRWEB) September 23, 2014 PM360, a leading health-marketing industry trade magazine, recognized the best innovators in the pharmaceutical industry with their annual Trailblazer Awards on Thursday, September 18, 2014. The honors, bestowed at a gala banquet at Gotham Hall in New York City, are given to outstanding companies, marketers and brand managers representing top talent and brands. “This industry...

2014-09-23 23:06:11

Standards-setting organization comments on proposal regarding International Nonproprietary Names of biotherapeutics Rockville, MD (PRWEB) September 23, 2014 The U.S. Pharmacopeial Convention (USP) has submitted comments to a proposal by the World Health Organization (WHO) regarding the assignment of Biological Qualifiers (BQ) to biotherapeutics. USP supports the effort by the Expert Group of the Programme of International Nonproprietary Names (INN) to develop a consensus-based global...


Latest Pharmacology Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

European Journal of Medical Chemistry
2012-05-12 22:03:06

The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...

0_3ff7149ca288229c28bcd855846ea8c7
2009-04-28 16:00:11

Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...

31_c737ff73aa3c47be364b2a8cce214e0c
2005-07-12 18:32:21

Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.

More Articles (5 articles) »
Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'